Bio Essence Corporation
BIOE
$0.05
-$0.01-10.96%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 565.70K | 563.60K | 346.20K | 324.00K | -28.70K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 565.70K | 563.60K | 346.20K | 324.00K | -28.70K |
| Cost of Revenue | 173.80K | 186.50K | 108.50K | 106.90K | 66.20K |
| Gross Profit | 391.90K | 377.10K | 237.70K | 217.10K | 110.20K |
| SG&A Expenses | 517.60K | 663.50K | 750.30K | 676.40K | 190.90K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 691.40K | 850.00K | 858.80K | 783.30K | -28.30K |
| Operating Income | -125.70K | -286.40K | -512.60K | -459.30K | -210.60K |
| Income Before Tax | -159.70K | -1.37M | -1.65M | -1.57M | -1.32M |
| Income Tax Expenses | 800.00 | 800.00 | 800.00 | 800.00 | -800.00 |
| Earnings from Continuing Operations | -0.16 | -1.37 | -1.65 | -1.57 | -1.32 |
| Earnings from Discontinued Operations | 0.00 | 0.00 | 0.00 | 256.90K | -154.60K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -160.50K | -1.37M | -1.65M | -1.31M | -1.48M |
| EBIT | -125.70K | -286.40K | -512.60K | -459.30K | -210.60K |
| EBITDA | -125.30K | -286.00K | -512.00K | -458.30K | -240.10K |
| EPS Basic | 0.00 | -0.04 | -0.04 | -0.03 | -0.04 |
| Normalized Basic EPS | 0.00 | -0.02 | -0.03 | -0.03 | -0.02 |
| EPS Diluted | 0.00 | -0.04 | -0.04 | -0.03 | -0.04 |
| Normalized Diluted EPS | 0.00 | -0.02 | -0.03 | -0.03 | -0.02 |
| Average Basic Shares Outstanding | 152.04M | 152.04M | 152.04M | 152.04M | 147.98M |
| Average Diluted Shares Outstanding | 152.04M | 152.04M | 152.04M | 152.04M | 147.98M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |